poLight ASA – resolution to increase the share capital

poLight ASA (the "Company") has a general share option scheme, whereby share options in the Company are granted to all employees.

The Company has received notices of exercise of 79 378 share options, including those share options exercised by primary insiders as disclosed on 2 March 2021. 8 333 of the share options hold an exercise price of NOK 74.90 per option, 34 990 of the share options hold an exercise price of NOK 50 per option, 18 389 of the share options hold an exercise price of NOK 27 and 17 666 of the share options hold an exercise price of NOK 18.90.

The Board of Directors has today resolved a share capital increase of NOK 15 875,60 through issuance of 79 378 new shares in order to satisfy the Company's obligation to deliver shares following exercise of share options. The new shares have been issued based on an authorization to increase the share capital granted to the Board of Directors on 28 May 2020.

Following completion of the share issuance, the share capital of the Company will be NOK 1,825,640.00 divided by 9 128 200 shares, each with a par value of NOK 0.20.

For additional information, please contact:

Øyvind Isaksen, CEO, poLight ASA: +47 90 87 63 98

About poLight ASA

poLight offers a new autofocus lens, which "replicates" the human eye, for use in devices such as smartphones, wearables, barcode readers, machine vision systems and various types of medical equipment. poLight's TLens® enables better system performance and new user experiences due to benefits such as extremely fast focus, small footprint, no magnetic interference, low power consumption and constant field of view. poLight is based in Horten, Norway, with offices in Finland, France and China and representation in Taiwan and Korea. For more information, please visit https://www.polight.com

This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.